Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies

Journal of the Neurological Sciences

Volumn 89, Issue 2-3, 1989, Pages 289-300

  Scolding, N J ^a   Morgan, B P ^a   Houston, A ^a   Campbell, A K ^a   Linington, C ^a   Compston, D A S ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Complement activation; Demyelinating diseases; Multiple sclerosis; Oligodendrocytes

Indexed keywords

COMPLEMENT;

ANIMAL CELL; CELL CULTURE; CYTOLOGY; CYTOTOXICITY; DEMYELINATION; MULTIPLE SCLEROSIS; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; RAT; SERUM;

ANIMAL; AUTOANTIBODIES; BLOOD PROTEINS; CELLS, CULTURED; COMPLEMENT ACTIVATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; MYELIN SHEATH; NEUROGLIA; OLIGODENDROGLIA; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T;

EID: 0024520296     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(89)90030-0     Document Type: Article

References (37)

1. Inflammatory vasculitis in multiple sclerosis
2. Purification and immunohistochemical localisation of rat brain myelin proteolipid protein
3. The ninth component of human complement: purification and physicochemical characterisation
4. Localisation of the glial fibrillary acidic protein in astrocytes by immunofluorescence
5. Paroxysmal nocturnal haemoglobinuria: enhanced stimulation of platelets by the terminal complement complex is related to the lack of C8 binding protein in the membrane
6. Oligodendrocytes: key cells in myelination and target in demyelinating diseases
7. A syringe modification for the simple and rapid dissociation of post-natal rat cerebral tissue for preparing primary cultures of mixed glial cells
8. Cerebrospinal fluid C9 in demyelinating disease
9. Immunocytochemical localisation of the terminal complement complex in multiple sclerosis
10. Antibody-independent complement activation by myelin via the classical complement pathway
11. Relationship between the increase in the diffusional permeability of the blood-CNS barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat
12. Oligoclonal banding in multiple sclerosis
13. Prazosin treatment suppresses increased vascular permeability in both acute and passive transferred EAE in the Lewis rat
14. Serum mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls
15. Electrophysiological investigations in adoptively transferred experimental allergic encephalomyelitis in the Lewis rat
16. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy
17. Myelin changes in the rat CNS following intraventricular injection of serum
18. Retinal venous sheathing in optic neuritis
19. The role of complement in the pathogenesis of experimental allergic encephalitis
20. Multiple sclerosis: rat and human oligodendrocytes are not the target for cerebrospinal fluid immunoglobulins
21. Myelination in rat brain: method of myelin isolation
22. Propidium iodide labelling of dead cells
23. The pathophysiology of myelin basic protein-induced experimental allergic encephalomyelitis in the Lewis rat
24. A glial cell precursor that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium
25. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside
26. Myelin-oligodendrocyte glycoprotein is a surface marker of oligodendrocyte maturation
27. Tissue culture studies of demyelinating disease
28. Optic nerve demyelination induced by human serum: Patients with multiple sclerosis or optic neuritis and normal subjects
29. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes
30. Myelin basic protein demonstrated immunocytochemically in oligodendrocytes prior to myelin sheath formation
31. Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: Assessment by Cr release assay
32. The development of complement activating ability as an age related factor in murine brains
33. Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis
34. The basis of intra-blood brain barrier IgG synthesis
35. A new model for multiple sclerosis chronic experimental allergic encephalomyelitis induced by immunisation with cerebral endothelial cell membrane
36. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies
37. Cobra venom factor: improved method for purification and biochemical characterisation